1,2-Benzisoxazole-3-acetamidoxime hydrochloride, a new psychotropic agent.
D000081:Acetamides / Q000494:pharmacology; D000374:Aggression / Q000187:drug effects; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007555:Isoxazoles; D009638:Norepinephrine / Q000378:metabolism; D010080:Oxazoles / Q000494:pharmacology*; D010091:Oximes / Q000494:pharmacology; D012110:Reserpine / Q000037:antagonists & inhibitors; D012640:Seizures / Q000139:chemically induced; D012890:Sleep / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology
D000081:Acetamides; D000928:Antidepressive Agents; D007555:Isoxazoles; D010080:Oxazoles; D010091:Oximes; D014149:Tranquilizing Agents; C006076:PF 257; D012110:Reserpine; D004298:Dopamine; D009638:Norepinephrine